NIH VideoCast - CC Grand Rounds: Clinicopathologic Grand Rounds: Clinical Cases from the NIH Clinical Center: Recombinant Anti-CD22 Immunotoxin Therapy of Drug-Resistant Hairy Cell Leukemia: Eradication of Minimal Residual Disease Without Chemotherapy Toxicity

Skip Navigation

CC Grand Rounds: Clinicopathologic Grand Rounds: Clinical Cases from the NIH Clinical Center: Recombinant Anti-CD22 Immunotoxin Therapy of Drug-Resistant Hairy Cell Leukemia: Eradication of Minimal Residual Disease Without Chemotherapy Toxicity

0 seconds of 0 secondsVolume 90%

00:25

00:00

00:00

266 Views

Air date:	Wednesday, February 18, 2015, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 266 (88 Live, 178 On-demand)
Category:	Clinical Center Grand Rounds
Runtime:	00:57:06
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	CC Grand Rounds: Clinicopathologic Grand Rounds: Clinical Cases from the NIH Clinical Center: Recombinant Anti-CD22 Immunotoxin Therapy of Drug-Resistant Hairy Cell Leukemia: Eradication of Minimal Residual Disease Without Chemotherapy Toxicity For more information go to http://www.cc.nih.gov/about/news/grcurrent.html

NLM Title:	Recombinant anti-CD22 immunotoxin therapy of drug-resistant hairy cell leukemia : eradication of minimal residual disease without chemotherapy toxicity / lead presenters: Ira Pastan, and Robert J. Kreitman.
Author:	Pastan, Ira H. Kreitman, Robert J. National Institutes of Health (U.S.),
Publisher:
Subjects:	Antineoplastic Agents--adverse effects Drug Resistance, Neoplasm Leukemia, Hairy Cell--drug therapy Sialic Acid Binding Ig-like Lectin 2
Publication Types:	Lecture Webcast

NLM Classification:	WH 250
NLM ID:	101654010
CIT Live ID:	15618
Permanent link:	https://videocast.nih.gov/watch=15618

Related Videos...